Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Nature-Inspired Optimization Algorithm and Machine Learning Techniques
DOI:
https://doi.org/10.21015/vtcs.v13i1.2079Abstract
PDAC is one of the most harmful cancer causes due to late diagnosis, its rapid progression, and an 11% survival rate of 5 years. Current methods for diagnosis are very costly, uncomfortable, and unreliable, However, better and more accurate solutions are needed. This study proposes a diagnostic model using urinary biomarkers and machine learning techniques for early detection. Key urinary biomarkers, including LYVE-1, REG1B, TFF1, and plasma CA19-9 are used with patient data. Particle Swarm Optimization is used here for feature selection and hyperparameter tuning, optimizes the machine learning classifiers like Support Vector Machine, Logistic Regression, and Random Forest. Accuracy, precision, recall, and F1-score are used as evaluation metrics; however, random forest achieves the highest accuracy of 89.83%. This study shows how PDAC detection changes after combining molecular diagnostics with machine learning. Future research could explore the study of hybrid swarm intelligence algorithms and increase the data set to make further enhancements to diagnostic capabilities. This model shows a great step toward a quick and accurate diagnosis of PDAC and improves patient outcomes and survival rates.
References
Karar ME, El-Fishawy N, Radad M. Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks. J Biol Eng. 2023;17(1):28.
Debernardi S, O’Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, et al. A combination of urinary biomarker panel and PancreaRisk score for earlier detection of pancreatic cancer: A case–control study. PLoS Med. 2020;17(12):e1003489.
Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73–85.
Han Y, Jung KJ, Kim U, Jeon CI, Lee K, Jee SH. Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: Metabolite genome-wide association study based on the KCPS-II cohort. J Transl Med. 2023;21(1):878.
Brezočnik L, Fister I Jr, Podgorelec V. Swarm intelligence algorithms for feature selection: A review. Appl Sci. 2018;8(9):1521.
Samir S, El-Ashry M, Soliman W, Hassan M. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Comput Biol Chem. 2024;112:108171.
Debernardi S, Blyuss O, Rycyk D, Srivastava K, Jeon CY, Cai H, et al. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Int J Cancer. 2023;152(4):769–80.
Blyuss O, Zaikin A, Cherepanova V, Munblit D, Kiseleva EM, Prytomanova OM, et al. Development of PancreaRisk, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. Br J Cancer. 2020;122(5):692–6.
LaValley MP. Logistic regression. Circulation. 2008;117(18):2395–9.
Acer I, Bulucu FO, Içer S, Latifoğlu F. Early diagnosis of pancreatic cancer by machine learning methods using urine biomarker combinations. Turk J Electr Eng Comput Sci. 2023;31(1):112–25.
Davis JJ. Urinary biomarkers for pancreatic cancer [Internet]. Kaggle; 2024 [cited 2025 Apr 28]. Available from: https://www.kaggle.com/datasets/johnjdavisiv/urinary-biomarkers-for-pancreatic-cancer
Sunarya PA, Rahardja U, Chen SC, Lic Y-M, Hardini M. Deciphering digital social dynamics: A comparative study of logistic regression and random forest in predicting e-commerce customer behavior. J Appl Data Sci. 2024;5(1):100–13.
Guido R, Ferrisi S, Lofaro D, Conforti D. An overview on the advancements of support vector machine models in healthcare applications: A review. Information. 2024;15(4):235.
Salman HA, Kalakech A, Steiti A. Random forest algorithm overview. Babylon J Mach Learn. 2024;2024:69–79.
Tang J, Liu G, Pan Q. A review on representative swarm intelligence algorithms for solving optimization problems: Applications and trends. IEEE/CAA J Autom Sin. 2021;8(10):1627–43.
Berreby R. Combining urinary biomarker panels and machine learning for earlier detection of pancreatic cancer [Internet]. SSRN; 2023 [cited 2025 Apr 28]. Available from: https://ssrn.com/abstract=4636409
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-By) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution License CC BY